-
1
-
-
78650343402
-
Transição demográfica e epidemiológica
-
Medronho RA, Bloch KV, Luiz RR, Werneck GL., 2.ed. São Paulo: Atheneu
-
Pontes RJ, Ramos-Júnior AN, Kerr LRS, Bosi MLM. Transição demográfica e epidemiológica. In: Medronho RA, Bloch KV, Luiz RR, Werneck GL. Epidemiologia. 2.ed. São Paulo: Atheneu; 2009. p. 123-52.
-
(2009)
Epidemiologia
, pp. 123-152
-
-
Pontes, R.J.1
Ramos Jr., A.N.2
Kerr, L.R.S.3
Bosi, M.L.M.4
-
2
-
-
68049111240
-
Prevalência de Chlamydia Pneumoniae e Mycoplasma Pneumoniae em diferentes formas da doença coronariana
-
Maia IL, Nicolau JC, Machado MN, Maia LN, Takakura IT, Rocha PRF, et al. Prevalência de Chlamydia Pneumoniae e Mycoplasma Pneumoniae em diferentes formas da doença coronariana. Arq Bras Cardiol. 2009; 92(6): 439-45.
-
(2009)
Arq Bras Cardiol
, vol.92
, Issue.6
, pp. 439-445
-
-
Maia, I.L.1
Nicolau, J.C.2
Machado, M.N.3
Maia, L.N.4
Takakura, I.T.5
Rocha, P.R.F.6
-
3
-
-
0035134609
-
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
-
Hadigan C, Meigs JB, Corcoran C, Rietschel P, Piecuch S, Basgoz N, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001; 32(1):130-9.
-
(2001)
Clin Infect Dis
, vol.32
, Issue.1
, pp. 130-139
-
-
Hadigan, C.1
Meigs, J.B.2
Corcoran, C.3
Rietschel, P.4
Piecuch, S.5
Basgoz, N.6
-
4
-
-
33845866857
-
Inflammation and metabolic disorders
-
Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121): 860-7.
-
(2006)
Nature
, vol.444
, Issue.7121
, pp. 860-867
-
-
Hotamisligil, G.S.1
-
5
-
-
76649085856
-
Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients
-
Domingos H, Cunha RV, Paniago AMM, Martins DM, Elkhoury EB, Souza AS. Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients. Braz J Infect Dis. 2009; 13(2): 130-6.
-
(2009)
Braz J Infect Dis
, vol.13
, Issue.2
, pp. 130-136
-
-
Domingos, H.1
Cunha, R.V.2
Paniago, A.M.M.3
Martins, D.M.4
Elkhoury, E.B.5
Souza, A.S.6
-
6
-
-
76149105182
-
Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV
-
Kramer AS, Lazzarotto AR, Sprinz E, Manfroi WC. Alterações metabólicas, terapia antirretroviral e doença cardiovascular em idosos portadores de HIV. Arq Bras Cardiol. 2009; 93(5): 561-8.
-
(2009)
Arq Bras Cardiol
, vol.93
, Issue.5
, pp. 561-568
-
-
Kramer, A.S.1
Lazzarotto, A.R.2
Sprinz, E.3
Manfroi, W.C.4
-
7
-
-
19344373051
-
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter Aids cohort study
-
Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter Aids cohort study. Arch Intern Med. 2005; 165(10): 1179-84.
-
(2005)
Arch Intern Med
, vol.165
, Issue.10
, pp. 1179-1184
-
-
Brown, T.T.1
Cole, S.R.2
Li, X.3
Kingsley, L.A.4
Palella, F.J.5
Riddler, S.A.6
-
8
-
-
28444483137
-
HIV infection and high-density lipoprotein: The effect of disease vs the effect of treatment
-
Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D. HIV infection and high-density lipoprotein: the effect of disease vs the effect of treatment. Metabolism. 2006; 55(1): 90-95.
-
(2006)
Metabolism
, vol.55
, Issue.1
, pp. 90-95
-
-
Rose, H.1
Woolley, I.2
Hoy, J.3
Dart, A.4
Bryant, B.5
Mijch, A.6
Sviridov, D.7
-
9
-
-
67651125105
-
Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis
-
Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009; 23(9): 1059-67.
-
(2009)
AIDS
, vol.23
, Issue.9
, pp. 1059-1067
-
-
Hsue, P.Y.1
Hunt, P.W.2
Schnell, A.3
Kalapus, S.C.4
Hoh, R.5
Ganz, P.6
-
10
-
-
36348999732
-
HIV-associated dyslipidaemia: Pathogenesis and treatment
-
Oh J, Hegele RA. HIV-associated dyslipidaemia: pathogenesis and treatment. Lancet Infect Dis. 2007; 7(12): 787-96.
-
(2007)
Lancet Infect Dis
, vol.7
, Issue.12
, pp. 787-796
-
-
Oh, J.1
Hegele, R.A.2
-
11
-
-
0038030965
-
Human immunodeficiency virus/ highly active antiretroviral therapy-associated metabolic syndrome: Clinical presentation, pathophysiology, and therapeutic strategies
-
Leow MK, Addy CL, Mantzoros CS. Human immunodeficiency virus/ highly active antiretroviral therapy-associated metabolic syndrome: clinical presentation, pathophysiology, and therapeutic strategies. J Clin Endocrinol Metab. 2003; 88(5): 1961-76.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, Issue.5
, pp. 1961-1976
-
-
Leow, M.K.1
Addy, C.L.2
Mantzoros, C.S.3
-
12
-
-
38949121641
-
Short-term effect of HAART on blood pressure in HIV-infected individuals
-
Grandominico CJ, Fichtenbaum JM. Short-term effect of HAART on blood pressure in HIV-infected individuals. HIV Clin Trials. 2008; 9(1): 52-60.
-
(2008)
HIV Clin Trials
, vol.9
, Issue.1
, pp. 52-60
-
-
Grandominico, C.J.1
Fichtenbaum, J.M.2
-
13
-
-
49249121166
-
Approach to the human immunodeficiency virus- -infected patient with lipodystrophy
-
Brown TT. Approach to the human immunodeficiency virus- -infected patient with lipodystrophy. J Clin Endocrinol Metab. 2008; 93(8): 2937-45.
-
(2008)
J Clin Endocrinol Metab
, vol.93
, Issue.8
, pp. 2937-2945
-
-
Brown, T.T.1
-
14
-
-
11344293751
-
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
-
Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(1): 48-62.
-
(2005)
N Engl J Med
, vol.352
, Issue.1
, pp. 48-62
-
-
Grinspoon, S.1
Carr, A.2
-
15
-
-
0032896389
-
Studies of body composition and fat distribution in HIV-infected and control subjects
-
Kotler DP, Rosenbaum K, Wang J, Pierson RN. Studies of body composition and fat distribution in HIV-infected and control subjects. J Acquir Immune Defic Syndr Hum Retrovirol. 1999;20(3):228-37.
-
(1999)
J Acquir Immune Defic Syndr Hum Retrovirol
, vol.20
, Issue.3
, pp. 228-237
-
-
Kotler, D.P.1
Rosenbaum, K.2
Wang, J.3
Pierson, R.N.4
-
16
-
-
34247537169
-
Class of antiretroviral drugs and the risk of myocardial infarction
-
DAD Study Group
-
DAD Study Group, Friis-Møller N, Reiss P, Sabin CA, Weber R, Monforte A, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007; 356(17): 1723-35.
-
(2007)
N Engl J Med
, vol.356
, Issue.17
, pp. 1723-1735
-
-
Friis-Møller, N.1
Reiss, P.2
Sabin, C.A.3
Weber, R.4
Monforte, A.5
-
17
-
-
44349148421
-
Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: Implications for cardiovascular risk
-
Tebas P, Henry WK, Matining R, Weng-Cherng D, Schmitz J, Valdez H, et al. Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk. PLoS One. 2008; 3(4): e2021.
-
(2008)
PLoS One
, vol.3
, Issue.4
-
-
Tebas, P.1
Henry, W.K.2
Matining, R.3
Weng-Cherng, D.4
Schmitz, J.5
Valdez, H.6
-
18
-
-
77950559517
-
The macrophage: The interection between HIV infection and atherosclerosis
-
Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M. The macrophage: the interection between HIV infection and atherosclerosis. J Leuk Biol. 2010; 87(1): 589-98.
-
(2010)
J Leuk Biol
, vol.87
, Issue.1
, pp. 589-598
-
-
Crowe, S.M.1
Westhorpe, C.L.2
Mukhamedova, N.3
Jaworowski, A.4
Sviridov, D.5
Bukrinsky, M.6
-
19
-
-
34248394654
-
Management of antiretroviral treatment- -related complications
-
Hoffman RM, Currier JS. Management of antiretroviral treatment- -related complications. Infect Dis Clin N Am. 2007; 21(1): 103-32.
-
(2007)
Infect Dis Clin N Am
, vol.21
, Issue.1
, pp. 103-132
-
-
Hoffman, R.M.1
Currier, J.S.2
-
20
-
-
67749111421
-
Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in c-reactive protein or fibrinogen
-
Lima LMA, Wiernsperger N, Kraemer-Aguiar LG, Bouskela E. Short-term treatment with metformin improves the cardiovascular risk profile in first-degree relatives of subjects with type 2 diabetes mellitus who have a metabolic syndrome and normal glucose tolerance without changes in c-reactive protein or fibrinogen. Clinics. 2009; 64(5): 415-20.
-
(2009)
Clinics
, vol.64
, Issue.5
, pp. 415-420
-
-
Lima, L.M.A.1
Wiernsperger, N.2
Kraemer-Aguiar, L.G.3
Bouskela, E.4
-
21
-
-
67650572201
-
Use of drugs that act on the cytochrome p450 system in the elderly
-
Cabrera MAS, Dip RM, Furlan MO, Rodrigues SL. Use of drugs that act on the cytochrome p450 system in the elderly. Clinics. 2009; 64(4): 273-8.
-
(2009)
Clinics
, vol.64
, Issue.4
, pp. 273-278
-
-
Cabrera, M.A.S.1
Dip, R.M.2
Furlan, M.O.3
Rodrigues, S.L.4
-
22
-
-
33750227103
-
A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy
-
Moyle GJ, Sabin CA, Cartledge J, Johnson M, Wilkins E, Churchill D, et al. A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy. Aids. 2006; 20(16): 2043-50.
-
(2006)
Aids
, vol.20
, Issue.16
, pp. 2043-2050
-
-
Moyle, G.J.1
Sabin, C.A.2
Cartledge, J.3
Johnson, M.4
Wilkins, E.5
Churchill, D.6
-
23
-
-
25444514523
-
Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: A prospective study
-
Guaraldi G, Orlando G, De Fazio D, De Lorenzi I, Rottino A, De Santis G, et al. Comparison of three different interventions for the correction of HIV-associated facial lipoatrophy: a prospective study. Antivir Ther. 2005; 10(6): 753-9.
-
(2005)
Antivir Ther
, vol.10
, Issue.6
, pp. 753-759
-
-
Guaraldi, G.1
Orlando, G.2
De Fazio, D.3
De Lorenzi, I.4
Rottino, A.5
De Santis, G.6
-
24
-
-
17244372383
-
Cardiovascular risk and body-fat abnormalities in HIV-infected adults
-
Behrens GM. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med. 2005; 352(16): 1721-2.
-
(2005)
N Engl J Med
, vol.352
, Issue.16
, pp. 1721-1722
-
-
Behrens, G.M.1
-
25
-
-
77954699155
-
The role of testosterone in type 2 diabetes and metabolic syndrome in men
-
Saad F. The role of testosterone in type 2 diabetes and metabolic syndrome in men. Arq Bras Endocrinol Metab. 2009; 53(8): 901-7.
-
(2009)
Arq Bras Endocrinol Metab
, vol.53
, Issue.8
, pp. 901-907
-
-
Saad, F.1
-
27
-
-
77954756025
-
Testosterona sérica e doença cardiovascular em homens
-
Sá EQC, Sá FCF, Guedes AD, Verreschi ITN. Testosterona sérica e doença cardiovascular em homens. Arq Bras Endocrinol Metab. 2009; 53(8): 915-22.
-
(2009)
Arq Bras Endocrinol Metab
, vol.53
, Issue.8
, pp. 915-922
-
-
Sá, E.Q.C.1
Sá, F.C.F.2
Guedes, A.D.3
Verreschi, I.T.N.4
-
28
-
-
59249096920
-
Liver cirrhosis and diabetes: Risk factors, phatophysiology, clinical implications and management
-
Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, phatophysiology, clinical implications and management. World J Gastroenterol. 2009: 15(3): 280-8.
-
(2009)
World J Gastroenterol
, vol.15
, Issue.3
, pp. 280-288
-
-
Garcia-Compean, D.1
Jaquez-Quintana, J.O.2
Gonzalez-Gonzalez, J.A.3
Maldonado-Garza, H.4
-
29
-
-
77954857094
-
Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection
-
Rouabhia S, Malek R, Bounecer H, Dekaken A, Bendali Amor F, Sadelaoud M, et al. Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection. World J Gastroenterol. 2010; 16(27): 3427-31.
-
(2010)
World J Gastroenterol
, vol.16
, Issue.27
, pp. 3427-3431
-
-
Rouabhia, S.1
Malek, R.2
Bounecer, H.3
Dekaken, A.4
Bendali, A.F.5
Sadelaoud, M.6
-
30
-
-
77956468283
-
The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection
-
Mohamadkhani A, Sayemiri K, Ghanbari R, Elahi E, Poustchi H, Montazeri G. The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Virol J. 2010; 14(7): 228.
-
(2010)
Virol J
, vol.14
, Issue.7
, pp. 228
-
-
Mohamadkhani, A.1
Sayemiri, K.2
Ghanbari, R.3
Elahi, E.4
Poustchi, H.5
Montazeri, G.6
-
31
-
-
59449099132
-
Liver Int. Hepatitis C, insulin resistance and diabetes: Clinical and pathogenic data
-
Serfaty L, Capeau J. Liver Int. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int. 2009; 29(Suppl2): 13-25.
-
(2009)
Liver Int
, vol.29
, Issue.SUPPL. 2
, pp. 13-25
-
-
Serfaty, L.1
Capeau, J.2
-
32
-
-
33746366223
-
Proinflammatory, cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study
-
Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory, cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study. Diabetes Care. 2006; 29(5): 1096-101.
-
(2006)
Diabetes Care
, vol.29
, Issue.5
, pp. 1096-1101
-
-
Lecube, A.1
Hernandez, C.2
Genesca, J.3
Simo, R.4
-
33
-
-
38649120719
-
Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
-
Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology. 2008; 134(2): 416-23.
-
(2008)
Gastroenterology
, vol.134
, Issue.2
, pp. 416-423
-
-
Moucari, R.1
Asselah, T.2
Cazals-Hatem, D.3
Voitot, H.4
Boyer, N.5
Ripault, M.P.6
-
34
-
-
67549093932
-
Type B insulin resistance developing during interferon-alpha therapy
-
Daniel AL, Houlihan JL, Blum JS, Walsh JP. Type B insulin resistance developing during interferon-alpha therapy. Endocr Pract. 2009; 15(2): 153-7.
-
(2009)
Endocr Pract
, vol.15
, Issue.2
, pp. 153-157
-
-
Daniel, A.L.1
Houlihan, J.L.2
Blum, J.S.3
Walsh, J.P.4
-
35
-
-
15744381704
-
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
-
Romero-Gomez M, Del Mar Viloria M, Andrade RJ, Salmeron J, Diago M, Fernandez-Rodriguez CM, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology. 2005; 128(3): 636-41.
-
(2005)
Gastroenterology
, vol.128
, Issue.3
, pp. 636-641
-
-
Romero-Gomez, M.1
del Mar Viloria, M.2
Andrade, R.J.3
Salmeron, J.4
Diago, M.5
Fernandez-Rodriguez, C.M.6
-
36
-
-
33847629709
-
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
-
Tolman KG, Fonseca V, Dalpiaz A, Tan MH. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care. 2007; 30(3): 734-43.
-
(2007)
Diabetes Care
, vol.30
, Issue.3
, pp. 734-743
-
-
Tolman, K.G.1
Fonseca, V.2
Dalpiaz, A.3
Tan, M.H.4
-
37
-
-
77952565412
-
Insulin resistance and response to antiviral therapy in chronic hepatitis C: Mechanisms and management
-
Del Campo JA, López RA, Romero-Gómez M. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management. Dig Dis. 2010; 28(1): 285-93.
-
(2010)
Dig Dis
, vol.28
, Issue.1
, pp. 285-293
-
-
del Campo, J.A.1
López, R.A.2
Romero-Gómez, M.3
-
38
-
-
13544253737
-
A randomized controlled trial of acarbose in hepatic encephalopathy
-
Gentile S, Guarino G, Romano M, Alagia IA, Fierro M, Annunziata S, et al. A randomized controlled trial of acarbose in hepatic encephalopathy. Clin Gastroenterol Hepatol. 2005; 3(2): 184-91.
-
(2005)
Clin Gastroenterol Hepatol
, vol.3
, Issue.2
, pp. 184-191
-
-
Gentile, S.1
Guarino, G.2
Romano, M.3
Alagia, I.A.4
Fierro, M.5
Annunziata, S.6
-
39
-
-
77956262741
-
Virus infections and type 1 diabetes risk
-
Roivainen M, Klingel K. Virus infections and type 1 diabetes risk. Curr Diab Rep. 2010; 10(5): 350-6.
-
(2010)
Curr Diab Rep
, vol.10
, Issue.5
, pp. 350-356
-
-
Roivainen, M.1
Klingel, K.2
-
40
-
-
79951991522
-
Enteroviral pathogenesis of type 1 diabetes
-
Hober D, Sane F. Enteroviral pathogenesis of type 1 diabetes. Discov Med. 2010; 10(51): 151-60.
-
(2010)
Discov Med
, vol.10
, Issue.51
, pp. 151-160
-
-
Hober, D.1
Sane, F.2
-
41
-
-
1542345055
-
Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells
-
Ylipaasto P, Klingel K, Lindberg AM, Otonkoski T, Kandolf R, Hovi T, et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia. 2004; 47(2): 225-39.
-
(2004)
Diabetologia
, vol.47
, Issue.2
, pp. 225-239
-
-
Ylipaasto, P.1
Klingel, K.2
Lindberg, A.M.3
Otonkoski, T.4
Kandolf, R.5
Hovi, T.6
-
42
-
-
67349224990
-
Infection and type 1 diabetes mellitus a two edged sword?
-
Goldberg E, Krause I. Infection and type 1 diabetes mellitus - a two edged sword? Autoimmun Rev. 2009; 8(8): 682-6.
-
(2009)
Autoimmun Rev
, vol.8
, Issue.8
, pp. 682-686
-
-
Goldberg, E.1
Krause, I.2
-
43
-
-
35148847322
-
Diabetes and the risk of tuberculosis: A neglected threat to public health?
-
Stevenson CR, Critchley JA, Forouhi NG, Roglic G, Williams BG, Dye C, et al. Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn. 2007; 3(3):228-45.
-
(2007)
Chronic Illn
, vol.3
, Issue.3
, pp. 228-245
-
-
Stevenson, C.R.1
Critchley, J.A.2
Forouhi, N.G.3
Roglic, G.4
Williams, B.G.5
Dye, C.6
-
44
-
-
48749129542
-
Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies
-
Jeon C, Murray M. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008; 5(7): e152.
-
(2008)
PLoS Med
, vol.5
, Issue.7
-
-
Jeon, C.1
Murray, M.2
-
45
-
-
1442275317
-
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
-
Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004; 27(3): 813-23.
-
(2004)
Diabetes Care
, vol.27
, Issue.3
, pp. 813-823
-
-
Pickup, J.C.1
-
46
-
-
71549126811
-
Tuberculosis and diabetes mellitus: Convergence of two epidemics
-
Dooley K, Chaisson R. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009; 9(12): 737-46.
-
(2009)
Lancet Infect Dis
, vol.9
, Issue.12
, pp. 737-746
-
-
Dooley, K.1
Chaisson, R.2
-
47
-
-
76649116564
-
Tuberculosis and AIDS co-morbidity in Brazil: Linkage of the tuberculosis and AIDS databases
-
Miranda AE, Golub JE, Lucena FF, Maciel EN, Gurgel MF, Dietze R. Tuberculosis and AIDS co-morbidity in Brazil: linkage of the tuberculosis and AIDS databases. Braz J Infect Dis. 2009; 13(2): 137-41.
-
(2009)
Braz J Infect Dis
, vol.13
, Issue.2
, pp. 137-141
-
-
Miranda, A.E.1
Golub, J.E.2
Lucena, F.F.3
Maciel, E.N.4
Gurgel, M.F.5
Dietze, R.6
-
48
-
-
0025793540
-
The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans
-
Gwilt PR, Nahhas RR, Tracewell WG. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clin Pharmacokinet. 1991; 20(6): 477-90.
-
(1991)
Clin Pharmacokinet
, vol.20
, Issue.6
, pp. 477-490
-
-
Gwilt, P.R.1
Nahhas, R.R.2
Tracewell, W.G.3
-
49
-
-
33748648360
-
Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes
-
Nijland HM, Ruslami R, Stalenhoef JE, Nelwan EJ, Alisjahbana B, Nelwan RH, et al. Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes. Clin Infect Dis. 2006; 43(7): 848-54.
-
(2006)
Clin Infect Dis
, vol.43
, Issue.7
, pp. 848-854
-
-
Nijland, H.M.1
Ruslami, R.2
Stalenhoef, J.E.3
Nelwan, E.J.4
Alisjahbana, B.5
Nelwan, R.H.6
-
50
-
-
0042163137
-
Pharmacokinetic interactions with rifampicin: Clinical relevance
-
Niemi M, Backman JT, Fromm MF, Neuvonen PJ, Kivisto KT. Pharmacokinetic interactions with rifampicin: clinical relevance. Clin Pharmacokinet. 2003; 42(9): 819-50.
-
(2003)
Clin Pharmacokinet
, vol.42
, Issue.9
, pp. 819-850
-
-
Niemi, M.1
Backman, J.T.2
Fromm, M.F.3
Neuvonen, P.J.4
Kivisto, K.T.5
-
51
-
-
0034979614
-
Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide
-
Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT. Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide. Clin Pharmacol Ther. 2001; 69(6): 400-6.
-
(2001)
Clin Pharmacol Ther
, vol.69
, Issue.6
, pp. 400-406
-
-
Niemi, M.1
Backman, J.T.2
Neuvonen, M.3
Neuvonen, P.J.4
Kivisto, K.T.5
-
52
-
-
71549160447
-
Increased insulin requirement in a patient with type 1 diabetes on rifampicin
-
Atkin S, Masson E, Bodmer C, Walker B, White M. Increased insulin requirement in a patient with type 1 diabetes on rifampicin. Diab Med. 1992; 10(4): 202.
-
(1992)
Diab Med
, vol.10
, Issue.4
, pp. 202
-
-
Atkin, S.1
Masson, E.2
Bodmer, C.3
Walker, B.4
White, M.5
-
53
-
-
79951974879
-
Avaliação dos níveis de lipídeos, lipoproteínas, apoproteínas e o papel da lipoproteína (a) no desenvolvimento de aterosclerose e alterações fibrinolíticas nos pacientes portadores de hanseníase virchowiana
-
Dalpino D, Magna LA, Opromolla DV. Avaliação dos níveis de lipídeos, lipoproteínas, apoproteínas e o papel da lipoproteína (a) no desenvolvimento de aterosclerose e alterações fibrinolíticas nos pacientes portadores de hanseníase virchowiana. Hansen Int. 1997; 22(2): 20-30.
-
(1997)
Hansen Int
, vol.22
, Issue.2
, pp. 20-30
-
-
Dalpino, D.1
Magna, L.A.2
Opromolla, D.V.3
-
54
-
-
77949355221
-
99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: Immune therapies of type 1 diabetes: New opportunities based on the hygiene hypothesis
-
Chatenoud L, You S, Okada H, Kuhn C, Michaud B, Bach JF. 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis. Clin Exp Immunol. 2010; 160(1): 106-12.
-
(2010)
Clin Exp Immunol
, vol.160
, Issue.1
, pp. 106-112
-
-
Chatenoud, L.1
You, S.2
Okada, H.3
Kuhn, C.4
Michaud, B.5
Bach, J.F.6
-
55
-
-
0014901004
-
Schistosomiasis and diabetes mellitus
-
Bibawi E. Schistosomiasis and diabetes mellitus. Trans R Soc Trop Med Hyg. 1970; 64(6): 907-8.
-
(1970)
Trans R Soc Trop Med Hyg
, vol.64
, Issue.6
, pp. 907-908
-
-
Bibawi, E.1
-
56
-
-
0032923558
-
Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice
-
Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, et al. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol. 1999; 21(4): 169-76.
-
(1999)
Parasite Immunol
, vol.21
, Issue.4
, pp. 169-176
-
-
Cooke, A.1
Tonks, P.2
Jones, F.M.3
O'Shea, H.4
Hutchings, P.5
Fulford, A.J.6
-
57
-
-
0031666963
-
An evaluation of the marmoset Callithrix jacchus (sagüi) as an experimental model for the dyslipoproteinemia of human Schistosomiasis mansoni
-
Lima VL, Sena VL, Stewart B, Owen JS, Dolphin PJ. An evaluation of the marmoset Callithrix jacchus (sagüi) as an experimental model for the dyslipoproteinemia of human Schistosomiasis mansoni. Biochim Biophys Acta. 1998; 1393(2-3): 235-43.
-
(1998)
Biochim Biophys Acta
, vol.1393
, Issue.2-3
, pp. 235-243
-
-
Lima, V.L.1
Sena, V.L.2
Stewart, B.3
Owen, J.S.4
Dolphin, P.J.5
-
58
-
-
0020472333
-
Diabetes mellitus associated with pentamidine mesylate
-
Belehu A, Naafs B. Diabetes mellitus associated with pentamidine mesylate. Lancet. 1982; 1(8287): 1463-4.
-
(1982)
Lancet
, vol.1
, Issue.8287
, pp. 1463-1464
-
-
Belehu, A.1
Naafs, B.2
-
59
-
-
0020492942
-
Visceral leishmaniasis presenting with hypertrigliceridaemia
-
Bertoli A, Greco AV, Caputo S, Caradonna P, Grieco A, Laghi V. Visceral leishmaniasis presenting with hypertrigliceridaemia. Lancet. 1982; 2(8296): 504-5.
-
(1982)
Lancet
, vol.2
, Issue.8296
, pp. 504-505
-
-
Bertoli, A.1
Greco, A.V.2
Caputo, S.3
Caradonna, P.4
Grieco, A.5
Laghi, V.6
-
60
-
-
0036022344
-
Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis
-
Liberopoulos E, Alexandridis G, Bairaktari E, Elisaf M. Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis. Ann Clin Lab Sci. 2002; 32(3): 305-8.
-
(2002)
Ann Clin Lab Sci
, vol.32
, Issue.3
, pp. 305-308
-
-
Liberopoulos, E.1
Alexandridis, G.2
Bairaktari, E.3
Elisaf, M.4
|